HOME >> BIOLOGY >> NEWS
Taxpayer Alliance applauds congressional mandate for NIH public access

Washington, DC June 15, 2006 The Alliance for Taxpayer Access (ATA) strongly supports the U.S. House Appropriations Committee's provision directing the National Institutes of Health (NIH) to require its research grantees to submit an electronic version of their final, peer-reviewed manuscript to the National Library of Medicine's PubMed Central online archive upon acceptance for publication in a journal.

The House Appropriations Committee took this official step, which strengthens the public access policy undertaken by NIH a year ago, as they approved the FY 2007 Labor, HHS, Education, and Related Agencies appropriations measure. The NIH policy, currently voluntary, has resulted in researchers' deposit of less than five percent of available NIH-funded research. The House Appropriations bill with the new directive will now be considered by the U.S. House of Representatives. The U.S. Senate will consider its Labor, HHS, Education, and Related Agencies Appropriations bill sometime this summer.

"This action is a clear signal from Congressional leaders that they are committed to advancing the cause of science and the public interest," said Heather Joseph, Executive Director of SPARC (the Scholarly Publishing and Academic Resources Coalition, an ATA founding member). "The bill is a significant step in acknowledging the profound impact the Internet has on the conduct of scientific research and the need for this research to be shared as widely as possible."

The bill also stipulates a maximum 12-month window for authors to submit their peer-reviewed manuscripts. The ATA believes this lengthy timeframe will delay important research advances and the dissemination of information to stakeholders who rely on it. "We applaud the House Appropriations Committee for taking this tremendous stride forward," said Pat Furlong, Founding President & CEO of Parent Project Muscular Dystrophy. "For individuals and families struggling to stay abreast of scientific dev
'"/>

Contact: Jennifer Heffelfinger
jennifer@arl.org
202-247-6185
SPARC
15-Jun-2006


Page: 1 2

Related biology news :

1. Taxpayer Alliance supports senate bill broadening access to federal research
2. Taxpayer advocacy group says Cures Bill is the right medicine
3. BG Group and Conservation International launch Conservation through Photography Alliance
4. Colon Cancer Alliance launches interactive support program
5. Wildlife Conservation Society joins Climate, Community & Biodiversity Alliance
6. TB Alliance and Bayer launch historic global drug trials for tuberculosis
7. Conservation International and AF&PA join forces to form Alliance to Combat Illegal Logging
8. Dietary Guidelines Alliance offers tools to help consumers understand new nutrition guidance
9. JDRF applauds important passage of the Stem Cell Research Enhancement Act of 2007
10. AAAS applauds nationwide science and math standards based on existing guidelines
11. BioMed Central applauds Wellcomes leadership on Open Access

Post Your Comments:
(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 ... (OTCQB: GNBT) today announced two presentations demonstrating that ... its novel proprietary cancer immunotherapeutic AE37 vaccine correlated ... patients. The AE37 cancer vaccine is being developed ... ( www.antigenexpress.com ). The presentations are being made ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2CU Denver study says upgrading infrastructure could reduce flood damage 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4
Cached News: